...
首页> 外文期刊>Circulation journal >Impact of Preoperative Fibrinogen Concentration on Postoperative Outcome in Patients Who Received Dual Antiplatelet Therapy in Proximity to Off-Pump Coronary Bypass Surgery
【24h】

Impact of Preoperative Fibrinogen Concentration on Postoperative Outcome in Patients Who Received Dual Antiplatelet Therapy in Proximity to Off-Pump Coronary Bypass Surgery

机译:接受非体外循环冠状动脉搭桥手术的双重抗血小板治疗的患者术前血纤蛋白原浓度对术后结果的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: ?Preoperative fibrinogen concentration is associated with increased blood loss at the lower end, and with hypercoagulability-related ischemic event at the higher end in cardiac patients. We evaluated the influence of preoperative fibrinogen concentration on blood loss and outcome in patients who received clopidogrel in proximity to off-pump coronary artery bypass surgery (OPCAB). Methods and Results: ?Medical records of 538 patients who received clopidogrel within 5 days of OPCAB (April 2007 to March 2012) were retrospectively reviewed. Perioperative bleeding and composite of morbidity endpoints including myocardial infarction were compared in relation to the tertile distribution of the fibrinogen concentration. The amount of blood loss was significantly larger in the first tertile, whereas the incidence of composite of morbidity endpoints was significantly higher in the third tertile. In multivariate analysis for risk factors of perioperative blood loss, body mass index and duration of surgery were identified as independent risk factors but not the fibrinogen level. And hypertension and preoperative fibrinogen level were identified as independent risk factors about composite of morbidity. The third tertile was associated with a 2-fold increased risk of developing composite of morbidity endpoints. Conclusions: ?In patients who received dual antiplatelet therapy in proximity to OPCAB, increased preoperative fibrinogen concentration could serve as a valuable predictor for composite of morbidity endpoints, whereas low fibrinogen concentration was not found to be a risk factor of bleeding.??( Circ J ?2014; 78: 1661–1666)
机译:背景:心脏疾病患者术前血纤蛋白原浓度的升高与血液流失的降低有关,而血液凝集素升高与缺血性事件的发生有关。我们评估了在非体外循环冠状动脉搭桥手术(OPCAB)附近接受氯吡格雷的患者术前血纤蛋白原浓度对失血量和预后的影响。方法和结果:回顾性分析了538例在OPCAB(2007年4月至2012年3月)内接受氯吡格雷的患者的医疗记录。比较了围手术期出血和包括心肌梗塞在内的各种疾病终点与纤维蛋白原浓度的三分位数分布的关系。在第一个三分位数中,失血量显着较大,而在第三个三分位数中,发病率终点复合指标的发生率显着更高。在围手术期失血危险因素的多因素分析中,体重指数和手术时间被确定为独立的危险因素,但不是纤维蛋白原水平。高血压和术前纤维蛋白原水平被确定为发病率的独立危险因素。第三个三分位数与罹患合并症终点的风险增加了2倍。结论:?在OPCAB附近接受双重抗血小板治疗的患者中,术前纤维蛋白原浓度的升高可作为发病率终点复合指标的重要预测指标,而低纤维蛋白原浓度未发现是出血的危险因素。 J?2014; 78:1661-1666)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号